Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SHR1701”

48 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 48 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07147088
What this trial is testing

Cryoablation Combined With SHR-1701 Plus Famitinib in Patients With Advanced Intrahepatic Cholangiocarcinoma.

Who this might be right for
Advanced Intrahepatic Cholangiocarcinoma
Fudan University 36
Testing effectiveness (Phase 2)Looking for participantsNCT07464756
What this trial is testing

SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer

Who this might be right for
Gastric Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University 80
Testing effectiveness (Phase 2)Looking for participantsNCT07689851
What this trial is testing

Chemoradiotherapy and SHR-1701 in Patients With Unresectable Gastric Cancer

Who this might be right for
Gastric Cancer (GC)Gastroesophageal Junction Adenocarcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05503888
What this trial is testing

Phase Ib/II Study of Almonertinib Combined With SHR-1701 in the Treatment of Relapsed or Advanced Non-small Cell Lung Cancer

Who this might be right for
Relapsed or Advanced Non-small Cell Lung Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 160
Early research (Phase 1)Ended earlyNCT05048134
What this trial is testing

A Phase I Study of HRS2300 or Combined With SHR-1316 or SHR-1701 or Trametinib or Almonertinib in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignancies
Jiangsu HengRui Medicine Co., Ltd. 13
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07517653
What this trial is testing

Neoadjuvant SHR-1701 Plus Famitinib With Response-guided Adjuvant Therapy in Resectable Mucosal Melanoma

Who this might be right for
Melanoma
Shanghai Zhongshan Hospital 70
Testing effectiveness (Phase 2)Study completedNCT04624217
What this trial is testing

A Trial of SHR-1701 in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Jiangsu HengRui Medicine Co., Ltd. 56
Testing effectiveness (Phase 2)UnknownNCT04580498
What this trial is testing

A Trial of SHR-1701 With or Without Chemotherapy in Patients With Stage III NSCLC

Who this might be right for
Non-Small-Cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 107
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07619911
What this trial is testing

SHR-1701 for Induction and Consolidation Therapy in Unresectable Stage III Non-Small Cell Lung Cancer

Who this might be right for
NSCLC Stage IIISHR-1701Chemoradiotherapy
Fudan University 84
Testing effectiveness (Phase 2)Looking for participantsNCT07294664
What this trial is testing

PDL1/TGFβ In Combination With SHR2554 or Apatinib And Chemotherapy For First - Line Treatment Of Gastric Cancer

Who this might be right for
Advanced Gastric CancerSHR1701
The First Affiliated Hospital of Zhengzhou University 78
Not applicableNot Yet RecruitingNCT07769866
What this trial is testing

Retlirafusp Alfa Combined With Chemoradiotherapy in Unresectable ESCC

Who this might be right for
Esophageal Squamous Cell Cancer
RenJi Hospital 68
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06679673
What this trial is testing

SHR-1701 Combined with SHR2554 and BP102 for MCRC

Who this might be right for
Colorectal Cancer Metastatic
Fudan University 20
Early research (Phase 1)UnknownNCT04282070
What this trial is testing

SHR-1701 in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 91
Testing effectiveness (Phase 2)UnknownNCT05106023
What this trial is testing

To Explore the Efficacy and Safety of SHR-1701 Combined With Temozolomide in the Treatment of Advanced Melanoma

Who this might be right for
Melanoma
Yong Chen 31
Testing effectiveness (Phase 2)UnknownNCT05896046
What this trial is testing

SHR1701 Alone or in Combination With SHR2554 in Relapsed or Refractory Classical Hodgkin Lymphoma

Who this might be right for
Relapsed or Refractory Hodgkin Lymphoma
Chinese PLA General Hospital 100
Large-scale testing (Phase 3)Ended earlyNCT05149807
What this trial is testing

Clinical Study of SHR-1701 Plus Chemotherapy as Perioperative Treatment in Subjects With Gastric Cancer

Who this might be right for
Perioperative Treatment in Subjects With Locally Advanced Resectable Gastric Cancer or Gastroesophageal Junction Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 81
Testing effectiveness (Phase 2)Study completedNCT04856774
What this trial is testing

Trial of SHR-1701 Plus BP102 in Subjects With Selected Solid Tumors

Who this might be right for
Advanced Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 81
Large-scale testing (Phase 3)UnknownNCT05132413
What this trial is testing

SHR-1701 Plus Bevacizumab and Chemotherapy in Non-Small-Cell-Lung-Cancer

Who this might be right for
Advanced or Metastatic Non-squamous Non-small-cell Lung Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 561
Early research (Phase 1)UnknownNCT03710265
What this trial is testing

SHR-1701 in Metastatic or Locally Advanced Solid Tumors

Who this might be right for
Solid Tumor
Jiangsu HengRui Medicine Co., Ltd. 206
Testing effectiveness (Phase 2)UnknownNCT04974957
What this trial is testing

Study of SHR-1701 Plus BP102 in Subjects With Selected Solid Tumors

Who this might be right for
Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 71
Next Page